ORIGINAL RESEARCH
Published on 29 Sep 2026
Personalized Boolean network dynamic profiling and machine learning approaches to identify combinatorial treatments for prostate cancer
doi 10.3389/fphar.2026.1869953
- 560 views
Articles
MINI REVIEW
Published on 25 Sep 2026
Beyond angiogenesis: the paradoxical emerging pro-tumorigenic role of Thrombospondin-2
doi 10.3389/fphar.2026.1897133
- 416 views
REVIEW
Published on 14 Sep 2026
The “ADC-after-ADC” paradigm: navigating cross-resistance and sequencing in breast cancer therapy
doi 10.3389/fonc.2026.1887974
- 1,495 views
ORIGINAL RESEARCH
Published on 30 Jul 2026
LncRNA FAM66C enhances gastric cancer proliferation and chemoresistance through phosphorylating nuclear YAP protein
doi 10.3389/fphar.2026.1749191
- 561 views
ORIGINAL RESEARCH
Published on 03 Jun 2026
The pterocarpan (+)-PTC modulates cytoskeletal proteins and induces apoptosis in metastatic castration-resistant prostate cancer: a proteomic perspective
doi 10.3389/fphar.2026.1770249
- 1,308 views
- 1 citation
ORIGINAL RESEARCH
Published on 25 May 2026
Clinicopathological and immunohistochemical analysis of poorly differentiated squamous cell carcinoma and its impact on quality of life
doi 10.3389/fphar.2026.1755491
- 1,151 views
ORIGINAL RESEARCH
Published on 14 May 2026
EZH2 blockade reverses doxorubicin resistance by inducing metabolic vulnerability and enhancing DNA damage in breast cancer
doi 10.3389/fphar.2026.1786648
- 1,649 views
- 1 citation
ORIGINAL RESEARCH
Published on 02 Apr 2026
Eprenetapopt in combination with carboplatin in high-grade ovarian and triple negative breast cancer cell lines with acquired resistance to olaparib
doi 10.3389/fonc.2026.1754873
- 1,769 views
